SILVERBERG, J. I.; KRAGH, N.; GUTTMAN-YASSKY, E.; WOLLENBERG, A. Treatment with tralokinumab improves health-related quality of life in adult patients with moderate to severe atopic dermatitis: results from a Phase 2b, randomised, double-blind, placebo-controlled study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, p. S64, 2018. DOI: 10.25251/skin.2.supp.64. Disponível em: https://www.jofskin.org/index.php/skin/article/view/460. Acesso em: 26 jan. 2023.